ANTHEM vs KOVAI: Stock Comparison

ANTHEM BIOSCIENCES vs KOVAI MEDICAL CENTER & HOUpdated 17 Sept 26, 12:12 PM ISTNSE & company filings

ANTHEM BIOSCIENCES is the larger company by market capitalisation. ANTHEM BIOSCIENCES shows a higher ROE, faster revenue growth and lower leverage, while KOVAI MEDICAL CENTER & HO shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ANTHEM leads 9; KOVAI leads 4 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ANTHEMKOVAI

Valuation lens

What price are you paying?

Market CapContext only
₹51,941 Cr
₹6,729 Cr
P/E RatioKOVAI has the lower reading
89.17x
25.96x
P/B RatioKOVAI has the lower reading
16.88x
5.04x
EPSKOVAI has the higher reading
₹10.09
₹63.14
Book ValueContext only
₹54.17
₹1,205.66
Dividend YieldKOVAI has the higher reading
0.21%
0.25%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ANTHEM is the larger company
₹51,941 Cr vs ₹6,729 Cr
P/E Ratio
KOVAI has a lower P/E
25.96x vs 89.17x
P/B Ratio
KOVAI has a lower P/B
5.04x vs 16.88x
EPS
KOVAI has higher earnings per share
₹63.14 vs ₹10.09
Dividend Yield
KOVAI has a higher dividend yield
0.25% vs 0.21%
Revenue Growth (TTM YoY)
ANTHEM has faster revenue growth
26.4% vs 0%
EPS Growth (TTM YoY)
ANTHEM has faster EPS growth
127.2% vs 0%
Qtr Sales Growth
ANTHEM has stronger quarterly sales growth
-8.22% vs -72.8%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricANTHEMKOVAI
SectorHealthcare
IndustryBiotechnology

Price

MetricANTHEMKOVAI
Live Price₹917.55₹6,175
Day Change1%1.43%
Volume1.73 L1,284
52-Week High₹977.55₹6,444
52-Week Low₹579.15₹5,275.5
Distance from 52W High-6.14%-4.17%

Valuation

MetricANTHEMKOVAI
Market Cap₹51,941 Cr₹6,729 Cr
P/E Ratio89.17x25.96x
P/B Ratio16.88x5.04x
EPS₹10.09₹63.14
Book Value₹54.17₹1,205.66
Dividend Yield0.21%0.25%

Growth

MetricANTHEMKOVAI
Revenue Growth (TTM YoY)26.4%0%
EPS Growth (TTM YoY)127.2%0%
Qtr Sales Growth-8.22%-72.8%
Qtr Profit Growth-14.95%-71.74%

Profitability & Leverage

MetricANTHEMKOVAI
ROE21.06%18.53%
ROCE22.79%16.52%
Net Margin26.05%15.42%
Operating Margin43.54%22.56%
Debt to Equity0.01x0.28x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricANTHEMKOVAI
Promoter Holding71.42% 3.26 pp55.81%
FII Holding2.58% 1.3 pp1.25% 0.05 pp
DII Holding13.48% 1.93 pp4.25% 0.23 pp
Public Holding12.53% 0.03 pp37.98% 0.18 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ANTHEM BIOSCIENCES and KOVAI MEDICAL CENTER & HO.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.